Cargando…
Will Regulatory and Financial Considerations Dampen Innovation in the Clinical Microbiology Laboratory?
Over a million prosthetic joints are placed in patients in the United States annually. Of those that fail, 25% will be due to infection, with an estimated cost approaching 1 billion dollars. Despite the clinical and economic importance of these infections, the techniques for their detection are rela...
Autores principales: | Gilligan, Peter H., Miller, Melissa B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742713/ https://www.ncbi.nlm.nih.gov/pubmed/26838721 http://dx.doi.org/10.1128/mBio.02178-15 |
Ejemplares similares
-
Clinical Failures of Linezolid and Implications for the Clinical Microbiology Laboratory
por: Potoski, Brian A., et al.
Publicado: (2002) -
Introducing New Laboratory-Developed Molecular Methods in the Clinical Microbiology Laboratories
por: Pouladfar, Gholamreza
Publicado: (2012) -
Clinical microbiology laboratories and COVID-19: the calm before the storm
por: M Blondeau, Joseph
Publicado: (2020) -
Laboratory Automation in the Microbiology Laboratory: an Ongoing Journey, Not a Tale?
por: Zimmermann, Stefan
Publicado: (2021) -
From Print to Screen: Regulatory Considerations to Adopting Innovative Approaches for Patient Information and Safety
por: Bolislis, Winona Rei R., et al.
Publicado: (2019)